Vasileios-periklis Stamatellos
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functions.
Journal: Asian journal of psychiatry
Published: June 27, 2025
Commentary: Coexistence of anti-NMDA receptor (NMDAR) encephalitis and MOGAD.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: March 22, 2025
Weight gain, gender, and antipsychotics: a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS).
Journal: Expert opinion on drug safety
Published: August 17, 2023
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models.
Journal: CNS & neurological disorders drug targets
Published: April 22, 2022
S1P receptor modulators in Multiple Sclerosis: Detecting a potential skin cancer safety signal.
Journal: Multiple sclerosis and related disorders
Published: December 28, 2021
Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects.
Journal: Multiple sclerosis and related disorders
Published: November 10, 2021
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS).
Journal: Current reviews in clinical and experimental pharmacology
Published: June 15, 2021
Disease-modifying agents for multiple sclerosis and the risk for reporting cancer: A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database.
Journal: British journal of clinical pharmacology
Published: March 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026